Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Incidence of glomerulonephritis in the western part of Switzerland over the last decade

Original article
Nanchen G, Schutzbach K, Rotman S, Winzeler R, Ambühl P, Halfon M, Pruijm M
Swiss Med Wkly. 2020;150:w20353

Glomerulonephritis is a rare yet serious group of diseases with a high risk of progression to end-stage renal disease. For optimal healthcare planning, detailed epidemiological and demographic data are essential.

Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how?

Review article: Biomedical intelligence
Lu H, Meyer P, Hullin R
Swiss Med Wkly. 2020;150:w20341

The authors present an up-to-date narrative literature review of the physiological mechanisms of action, current indications, therapeutic utility and side effects of SGLT2 inhibitors.

Paediatric end-stage renal disease and renal replacement therapy in Switzerland: survival and treatment trends over four decades

Original article
Maurer E, Neuhaus TJ, Weitz M, Kuehni CE, Laube GF
Swiss Med Wkly. 2020;150:w20300

Copeptin-based diagnosis of diabetes insipidus

Review article: Biomedical intelligence
Refardt J, Christ-Crain M
Swiss Med Wkly. 2020;150:w20237

With the establishment of copeptin, a stable and reliable surrogate marker for arginine vasopressin, diagnosis of the polyuria-polydipsia syndrome has been newly evaluated.

Use of day and night urinary iodine excretion to estimate the prevalence of inadequate iodine intakes via the estimated average requirement cut-point method

Original article
Stalder E, Haldimann M, Blanc A, Dudler V, Ponte B, Pruijm M, Ackermann D, Bochud M
Swiss Med Wkly. 2019;149:w20090

Segregating 24-hour urine into day and night collections is sufficient to determine the prevalence of iodine inadequacy in the population.

Reality check: primary vascular access creation today

Original article
Jann T, Wyss TR, Gahl B, Kalicki RM, Uehlinger DE, Widmer MK
Swiss Med Wkly. 2018;148:w14668

In Switzerland, the outcome of vascular access creation in the 4500 patients on dialysis is unknown, mainly because there is no prospective registry for patients undergoing vascular access surgery for renal replacement therapy.

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials

Systematic review
Mavrakanas TA, Aurian-Blajeni DE, Charytan DM
Swiss Med Wkly. 2017;147:w14507

Pre-emptive dialysis could theoretically improve outcomes in critically ill patients, but might expose patients who would shortly recover enough renal function to stay off dialysis to dialysis-related complications.

Early complications after living donor nephrectomy: analysis of the Swiss Organ Living Donor Health Registry

Original article
Burkhalter F, Huynh-Do U, Hadaya K, Matter M, Müller T, Binet I, Nolte C, Steiger J
Swiss Med Wkly. 2017;147:w14497

Despite the increase of living kidney donation during past decades there are only a few articles reporting prospectively collected cohort data about perioperative, short-term and long-term complications after living donor nephrectomy.

Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices

Original article
Corcillo A, Pivin E, Lalubin F, Pitteloud N, Burnier M, Zanchi A
Swiss Med Wkly. 2017;147:w14459

Specific goals for blood glucose, blood pressure and lipid control have been defined for diabetes patients. Primary care physicians have difficulty in reaching all goals, as time dedicated to the care of patients in an outpatient setting is confined.

Verpassen Sie keinen Artikel!